Raymond James Financial’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$18.4K	Buy	+1,618	New	+$18.4K	﹤0.01%	5559
2025 Q1	–	Sell	-54,453	Closed	-$1.03M	–	4824
2024 Q4	$1.03M	Buy	+54,453	New	+$1.03M	﹤0.01%	3426